Episurf Medical
0.359 SEK -2.45%1 investor is following this company
Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.
Revenue
10.3M
EBIT %
-938.83 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
EPIS B
Daily low / high price
0.33 / 0.389
SEK
Market cap
95.88M SEK
Turnover
559.55K SEK
Volume
1.6M
Latest videos
Financial calendar
Extraordinary general meeting
2024-05-22
Interim report
2024-07-12
Interim report
2024-10-25
Annual report
2025-02-07
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Health Runner | 13.0 % | 13.0 % |
Fjärde AP-Fonden | 4.7 % | 4.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Episurf: INTERIM REPORT 1 JANUARY - 31 MARCH 2024
Episurf: DELÅRSRAPPORT 1 JANUARI - 31 MARS 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools